1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TTC9 CTRPv2 pan-cancer AAC 0.087 0.01
mRNA PRKCB CTRPv2 pan-cancer AAC -0.099 0.01
mRNA RP11-345F18.1 CTRPv2 pan-cancer AAC -0.082 0.01
mRNA HDC CTRPv2 pan-cancer AAC -0.082 0.01
mRNA PCDHA11 CTRPv2 pan-cancer AAC 0.093 0.01
mRNA MBOAT7 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA SLA2 CTRPv2 pan-cancer AAC -0.084 0.01
mRNA RP5-1052I5.2 CTRPv2 pan-cancer AAC 0.085 0.01
mRNA KLHL31 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA IFNL1 CTRPv2 pan-cancer AAC 0.081 0.01
Download CSV